Portfolio news 0

Accelercomm Ltd

AccelerComm participates in Airbus UpNext SpaceRAN Demonstrator, Advancing Global 5G Connectivity in Space

Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting

OXCCU

OXCCU Named on the 2026 Global Cleantech 100

First Light Fusion Ltd

First Light Fusion achieves JOSCAR registration, strengthening trust and opening new opportunities

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Full Year Trading Update and Notice of Results

MoA Technology Ltd

Moa Technology and Certis Belchim announce strategic collaboration for new Moa Amplifier™

Storm Therapeutics

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

Pulmocide

Pulmocide announces termination of Opera-T Phase 3 study with Opelconazole

Oxford Quantum Circuits Limited

OQC Appoints Darko Stojkovic as Chief Operating Officer to Strengthen Global Leadership and Operational Scale-Up

Iksuda Therapeutics Ltd

Iksuda to present preliminary analysis of oesophageal cancer data from Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium